上海医药集团股份有限公司（02607）于2026年10月2日披露截至2026年9月30日的证券变动月报。报告显示，本月公司已发行股份结构保持稳定，未发生新增发行、购回或注销情况。
具体来看，截至2026年9月30日，公司H股普通股已发行股份数量为919,072,704股，与上个月持平，库存股份为0股；A股普通股已发行股份数量为2,789,289,105股，库存股份为0股，两者均未发生变动。截至本月末，法定/注册股本总额为人民币3,708,361,809元。
公告披露，公司在报告期内无任何期权或股权激励计划相关变动，也不存在任何购回及注销活动。公司再次强调，已严格遵守香港联合交易所有限公司《上市规则》及相应的法律法规。公告由公司联席公司秘书钟涛签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.